Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer
1 clinical trials · Condition
◉ Watch Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer
| Record | Firm | Date |
|---|---|---|
| Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study (NCT03891238) | Consorzio Oncotech | 2019-02-06 |
Track Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer automatically
Every clearance here is in the API, with alerts when new ones post.